Literature DB >> 3995178

Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome.

L Corash, B Shafer, R M Blaese.   

Abstract

Wiskott-Aldrich syndrome (WAS) thrombocytopenia is frequently improved by splenectomy, although the mechanism of the thrombocytopenia and its resolution are unknown. Previous studies in two patients have shown that mean platelet volume, which is characteristically reduced in WAS, increased along with platelet count postsplenectomy. Additional studies in a limited number of patients have also demonstrated that platelet-associated immunoglobulin G (PAIgG) is elevated presplenectomy, but to date no postsplenectomy data have been reported. The present study was performed to more fully evaluate the effect of splenectomy on platelet volume and PAIgG in WAS. Before splenectomy, mean platelet volume was reduced but platelet size was broadly distributed with substantial overlap of the normal range. PAIgG was significantly elevated in 13 of 14 presplenectomy WAS patients (means = 78.9 fg per platelet) and fell to normal levels postoperatively (means = 4.0 fg per platelet). Platelet count and clinical status improved postsplenectomy, and mean platelet volume and platelet volume distribution returned to the normal range. WAS subjects who relapsed with recurrent thrombocytopenia redeveloped elevated PAIgG but maintained normal platelet size. The spleen appears to play a critical role in a process that may be immunologically mediated and results in reduced platelet size.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995178

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Novel clearance mechanisms of platelets.

Authors:  Renata Grozovsky; Karin M Hoffmeister; Hervé Falet
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 2.  Wiskott-Aldrich syndrome: a multidisciplinary disease.

Authors:  G R Standen
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

3.  Current Strategies in Diagnosis of Inherited Storage Pool Defects.

Authors:  Kirstin Sandrock; Barbara Zieger
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

4.  Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.

Authors:  Amanda Prislovsky; Bindumadhav Marathe; Amira Hosni; Alyssa L Bolen; Falk Nimmerjahn; Carl W Jackson; Darryl Weiman; Ted S Strom
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

5.  Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP.

Authors:  Hervé Falet; Michael P Marchetti; Karin M Hoffmeister; Michel J Massaad; Raif S Geha; John H Hartwig
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

Review 6.  The thrombocytopenia of WAS: a familial form of ITP?

Authors:  Ted S Strom
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

7.  WASP plays a novel role in regulating platelet responses dependent on alphaIIbbeta3 integrin outside-in signalling.

Authors:  Anna Shcherbina; Jessica Cooley; Maxim I Lutskiy; Charaf Benarafa; Gary E Gilbert; Eileen Remold-O'Donnell
Journal:  Br J Haematol       Date:  2009-10-27       Impact factor: 6.998

8.  Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.

Authors:  Y L Lau; B M Jones; L C Low; S N Wong; N K Leung
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

9.  Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption.

Authors:  Bindumadhav M Marathe; Amanda Prislovsky; Alexander Astrakhan; David J Rawlings; Jim Y Wan; Ted S Strom
Journal:  Exp Hematol       Date:  2009-09-03       Impact factor: 3.084

10.  The effect of a salmon diet on blood clotting, platelet aggregation and fatty acids in normal adult men.

Authors:  G J Nelson; P C Schmidt; L Corash
Journal:  Lipids       Date:  1991-02       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.